| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-14 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-12 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-09 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |